News
London’s FTSE 100 was up 0.4% at 8,888.02 in afternoon trade on Monday. Entain was the top gainer on the index as the ...
A “heavy workload” and “limited resources” have left the agency unable to meet a June 17 deadline to approve a therapy ...
1h
Zacks Investment Research on MSNIs Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Amarin (AMRN) been one of those stocks this year? A quick glance at the ...
GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support ...
The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.
During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in ...
Mortality rates specific to asthma have been falling, according to an abstract presented at the American Thoracic Society International Conference. Yet patients with one or more ED visit or ...
Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow ...
There were some movers and shakers while we were on the show floor. Let's get caught up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results